NCT06875245View on ClinicalTrials.gov

Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions
Wet Age-related Macular Degeneration
Interventions
DRUG

Faricimab Injection

Intravitreal Injection

Trial Locations (1)

100 34

RECRUITING

Department of Ophthalmology, Faculty hospital Kralovske Vinohrady, Prague

All Listed Sponsors
lead

Faculty Hospital Kralovske Vinohrady

OTHER_GOV